Hydrodissection of the Hepatoduodenal Ligament

N/AUnknownNCT06190821

University Hospital, Strasbourg, France13 enrolled

Overview

Percutaneous treatment of liver lesions adjacent to the duodenum exposes the duodenum to the risk of thermal injury, limiting removal and oncologic outcome. In this study the investigators investigate the feasibility of hepato duodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hepatic Lesions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Major subject (≥18 years of age) * Subject who underwent percutaneous ablation of primary or secondary liver lesions at HUS that required per-procedure hepatoduodenal ligament hydrodissection in the interventional imaging department of the New Civil Hospital from January 2019 to July 2022. * Subject who has not expressed opposition to the reuse of their data for the purpose of this research. Exclusion Criteria: \- Opposition to the reuse of his/her data for the purpose of scientific research.

Locations (1)

Service Imagerie interventionnelle oncologique et viscérale - CHU de Strasbourg - France

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Retrospective description of the hepatoduodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum

This study is retrospective

Time frame: Files analysed retrospectively from January 01, 2019 to July 31, 2022 will be examined

Central Contacts

Julien GARNON, MD

CONTACT

33 3.69.55.03.04 julien.garnon@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.